Bonesupport Holding AB (publ)
0RQO.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.64B
Close$
$-153.05
160.7% downside
Current Fair Value
160.7% downsideOvervalued by 160.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.64 Billion |
|---|---|
| Enterprise Value | $15.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.16 |
| Beta | 0.49 |
| Outstanding Shares | 65,858,999 |
Return
| Return on Equity | 22.53% |
|---|---|
| Return on Assets | 19.10% |
| Return on Invested Capital | 32.76% |
Valuation & Multiples
| P/E Ratio | 73.21 |
|---|---|
| PEG | 134.87 |
| Price to Sales | 13.26 |
| Price to Book Ratio | 18.0 |
| Enterprise Value to Revenue | 11.82 |
| Enterprise Value to EBIT | 48.71 |
| Enterprise Value to Net Income | 71 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 16, 2026
EPS Estimate
$1.13
Average shareholder expectationRevenue Estimate
$362.42 M
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
$1.33
Average shareholder expectationRevenue Estimate
$393.12 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bonesupport Holding AB (publ)
160 employees
CEO: Torbjorn Skold Bonesupport Holding AB (publ) operates as a prominent orthobiologics firm, dedicated to the development and worldwide commercialization of injectable bioceramic bone graft alternatives. These solutions are utilized for filling bone voids...